DRUG vs. ^GSPC
Compare and contrast key facts about Bright Minds Biosciences Inc (DRUG) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DRUG or ^GSPC.
Correlation
The correlation between DRUG and ^GSPC is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DRUG vs. ^GSPC - Performance Comparison
Key characteristics
DRUG:
1.87
^GSPC:
0.49
DRUG:
25.59
^GSPC:
0.81
DRUG:
4.06
^GSPC:
1.12
DRUG:
27.87
^GSPC:
0.50
DRUG:
104.66
^GSPC:
2.00
DRUG:
26.01%
^GSPC:
4.76%
DRUG:
1,461.48%
^GSPC:
19.36%
DRUG:
-97.67%
^GSPC:
-56.78%
DRUG:
-45.10%
^GSPC:
-8.79%
Returns By Period
In the year-to-date period, DRUG achieves a -14.99% return, which is significantly lower than ^GSPC's -4.72% return.
DRUG
-14.99%
-15.20%
-34.57%
2,844.23%
N/A
N/A
^GSPC
-4.72%
-0.51%
-1.78%
11.67%
14.69%
10.26%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DRUG vs. ^GSPC — Risk-Adjusted Performance Rank
DRUG
^GSPC
DRUG vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bright Minds Biosciences Inc (DRUG) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
DRUG vs. ^GSPC - Drawdown Comparison
The maximum DRUG drawdown since its inception was -97.67%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for DRUG and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
DRUG vs. ^GSPC - Volatility Comparison
Bright Minds Biosciences Inc (DRUG) has a higher volatility of 21.59% compared to S&P 500 (^GSPC) at 14.11%. This indicates that DRUG's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.